Limited time75% off all plans
Get the app

Pulmonary embolism

On this page

Quick Overview

Pulmonary embolism (PE) is a life-threatening condition requiring rapid diagnosis and treatment. NICE NG158 provides a structured approach using clinical probability assessment (Wells score), D-dimer testing, and imaging to confirm diagnosis, with immediate anticoagulation for most suspected cases. Risk stratification guides safe outpatient management versus admission.

Core Facts & Concepts

Two-Level PE Wells Score

  • PE likely (>4 points): Proceed directly to CTPA
  • PE unlikely (≤4 points): D-dimer first; if positive → CTPA
Clinical FeaturePoints
Clinical signs of DVT3
PE most likely diagnosis3
Heart rate >100 bpm1.5
Immobilisation/surgery (past 4 weeks)1.5
Previous PE/DVT1.5
Haemoptysis1
Malignancy (active/within 6 months)1

D-dimer Limitations

  • High sensitivity (>95%), low specificity (~50%)
  • False positives: pregnancy, malignancy, infection, post-op, elderly, hospitalised patients
  • Age-adjusted threshold: age × 10 μg/L (for age >50 years)
  • 🚩 Never use in "PE likely" patients - delays diagnosis

Figure 1: CT pulmonary angiography showing filling defect in right pulmonary artery

Imaging Selection (NICE NG158)

  • First-line: CTPA - sensitivity 83%, specificity 96%
  • V/Q scan if: contrast allergy, renal impairment (eGFR <30), pregnancy with normal CXR
  • V/Q reported as: normal, low/intermediate/high probability

Immediate Anticoagulation

  • Start before imaging if Wells >4 AND delay >1 hour expected
  • Options: DOAC (apixaban/rivaroxaban), LMWH, or fondaparinux
  • 📊 Contraindications: active bleeding, platelets <50×10⁹/L, recent neurosurgery

Problem-Solving Approach

Step-by-Step Diagnostic Pathway

  1. Calculate two-level Wells score immediately
  2. Wells ≤4 (PE unlikely):
    • Measure D-dimer (age-adjusted if >50 years)
    • Negative D-dimer → PE excluded, no imaging
    • Positive D-dimer → CTPA (or V/Q if contraindicated)
  3. Wells >4 (PE likely):
    • Start anticoagulation if imaging delay >1 hour
    • Arrange immediate CTPA (or V/Q)
  4. PE confirmed → Risk stratify using sPESI

Figure 2: ECG showing sinus tachycardia with S1Q3T3 pattern

🚩 Red Flags for Massive PE

  • Systolic BP <90 mmHg or drop >40 mmHg
  • Syncope, altered consciousness
  • Severe hypoxia (SpO₂ <90%)
  • Cardiac arrest
  • Consider thrombolysis (alteplase 50 mg IV over 1-2 hours)

Analysis Framework

Risk Stratification: Simplified PESI (sPESI)

ParameterPoints if Present
Age >80 years1
Cancer1
Chronic cardiopulmonary disease1
Heart rate ≥110 bpm1
Systolic BP <100 mmHg1
SpO₂ <90%1
  • sPESI = 0: Low risk → outpatient management safe (mortality <1%)
  • sPESI ≥1: Higher risk → consider admission, troponin/BNP, echo

Outpatient Management Criteria (All Must Apply)

  • sPESI = 0
  • No active bleeding/high bleeding risk
  • Adequate social support
  • Normal renal/hepatic function (for DOACs)
  • Follow-up within 24 hours arranged

Visual Aid

CTPA vs V/Q Selection

FactorCTPAV/Q Scan
First-line
Renal impairment (eGFR <30)
Contrast allergy
Pregnancy with normal CXR
AvailabilityWidely availableLimited centres

Key Points Summary

Two-level Wells >4 = PE likely → skip D-dimer, go straight to CTPA; start anticoagulation if imaging delayed >1 hour

Age-adjusted D-dimer (age × 10 μg/L for >50 years) reduces false positives in elderly; never use in "PE likely" patients

CTPA is first-line imaging; V/Q scan reserved for renal impairment, contrast allergy, or pregnancy with normal CXR

sPESI = 0 permits safe outpatient management (mortality <1%); sPESI ≥1 requires admission and further risk assessment

DOACs (apixaban/rivaroxaban) are first-line anticoagulation; no bridging with LMWH needed unlike warfarin

Massive PE (hypotension/arrest) → consider thrombolysis with alteplase 50 mg IV; contraindications include recent surgery/stroke

Common pitfall: Delaying anticoagulation in high-probability PE waiting for imaging - start treatment first if Wells >4 and delay expected

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE